PRME CIK: 1894562

Prime Medicine, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.5
FY22:
−117
FY23:
−205
FY24:
−202
FY25:
−208
(positive)
Change from FY21 to FY25
millions USD
FY21:
−83.5
FY22:
−106
FY23:
–
FY24:
−196
FY25:
−201
(positive)
Change from FY21 to FY25
millions USD
FY21:
−166
FY22:
−123
FY23:
–
FY24:
−196
FY25:
−201
(positive)
Change from FY21 to FY25
millions USD
FY21:
−165
FY22:
−122
FY23:
−198
FY24:
−196
FY25:
−201

All amounts in millions USD Data sources:SEC EDGARTwelve Data